HO

Hematological Oncology

Hematological Oncology is a peer-reviewed journal at the interface of hematology and oncology research. It publishes experimental and clinical articles on blood cancers and neoplastic diseases of the hemopoietic and lymphoid systems, including translational studies, clinical practice and management of hematological neoplasia, diagnostic investigations, imaging and laboratory assays, and therapeutic issues.

Looking to publish in Hematological Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Hematology, Oncology
Impact Factor 3.9
Quartile Q1
Open Access Type Hybrid
ISSN 0278-0232
eISSN 1099-1069
Invitation Only No
Cost Range $4,880 USD / £3,270 GBP / €4,110 EUR APC for open access articles if accepted and published.

Submission Instructions

Hematological Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Article

Cover Letter A covering letter signed by the corresponding author is required. The covering letter must state that all authors confirm the work has not been published and is not being considered for publication elsewhere.
Abstract An abstract is required. The abstract must be unstructured and less than 300 words. The abstract must be unstructured.
Manuscript The article must not exceed 3000 words excluding references. The main body must be formatted as introduction, materials and methods, results, discussion, and conclusion. The manuscript must include 3-6 keywords and a data availability statement.
References Original Articles may include a maximum of 80 references. References must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document and may be submitted as separate files. Figures and tables must have legends.
Reformat to Hematological Oncology using Livewrite Premium

Review

Cover Letter A covering letter signed by the corresponding author is required. The covering letter must state on behalf of all authors that the work has not been published and is not being considered for publication elsewhere.
Abstract An abstract is required. The abstract must be unstructured and less than 300 words. The abstract must be unstructured.
Manuscript The main body must be formatted as introduction, materials and methods, results, discussion, and conclusion. The manuscript must include 3-6 keywords and a data availability statement.
References References must follow AMA style. References may be submitted in any consistent style or format at initial submission, but the manuscript references must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document and should be uploaded as separate files. Figures and tables must include legends, and tables must be supplied as editable files rather than pasted as images.
Reformat to Hematological Oncology using Livewrite Premium

Letter To The Editor

Cover Letter A covering letter signed by the corresponding author must be included. The covering letter must state that all authors confirm the work has not been published and is not under consideration elsewhere.
Abstract Abstract must not exceed 300 words. Abstract must be unstructured.
Manuscript Article must not exceed 3000 words excluding references. Main body must be formatted as introduction, materials and methods, results, discussion, and conclusion. Manuscript must include a data availability statement and 3-6 keywords.
References Reference list may include a maximum of 10 references. References must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document and may be uploaded as separate files. Figures and tables must include legends.
Reformat to Hematological Oncology using Livewrite Premium

Case Report

Cover Letter A covering letter signed by the corresponding author must be included.
Abstract An abstract is required. Abstract must be unstructured and less than 100 words. Abstract must be unstructured.
Manuscript Case Reports must not exceed 1,500 words. Manuscript must include the sections abstract, introduction, methods, results, and conclusions. Manuscript must include a data availability statement and 3-6 keywords.
References Case Reports may include a maximum of 10 references. References must follow AMA style.
Figures & Tables Figures must not be embedded in the Word document. Figures and tables must have legends.
Reformat to Hematological Oncology using Livewrite Premium

Recent Publications

Adjusted Indirect Comparison Between Epcoritamab‐R 2 and Tafasitamab‐R 2 in Relapse/Refractory Follicular Lymphoma

Leonidas Benetatos, Elisavet Apostolidou, Vasileios Georgoulis, Georgios S. Markopoulos, Savvas Dimitriadis, Eleftheria Hatzimichael, Eleni Kapsali

10.1002/hon.70282
View Publication

APOBEC Status Classification Using a Curated Gene Panel in Multiple Myeloma

Dimitris Vraxnos, Paris Vogazianos, Cameron Brown, Marta Lionetti, Juan Carlos Entizne, Emily Charalambous, Athos Antoniades, Niccolo Bolli

10.1002/hon.70269
View Publication

Characterization of Adverse Cutaneous Effects in the Setting of Ponatinib, Bosutinib, and Asciminib for Chronic Myeloid Leukemia Patients

Ruhi Kanwar, Juna Khang, Goranit Sakunchotpanit, Ruhi Nayak, Nicole R. LeBoeuf, Vinod E. Nambudiri

10.1002/hon.70280
View Publication

Teclistamab Induced a Profound Hematologic Response in Light Chain Deposition Disease With Probable Cardiac Involvement

Xinyi Xiong, Danqing Zhao, Jian Li, Kaini Shen

10.1002/hon.70278
View Publication

Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis

Sohaib Irfan, Harshit Khosla, Saad Nasir, Manmeet Kaur, Tyler J. Varisco, Onyebuchi Ononogbu, Sharda Singh, Muhammad Bilal Abid

10.1002/hon.70268
View Publication

Frequently asked questions

How long does it take to publish?

Median submission to first decision is 13 days, median submission to acceptance is 96 days, and median acceptance to publication is 12 days.

Reformat to Hematological Oncology using Livewrite Premium

Is a cover letter required?

A covering letter is required, signed by the corresponding author, stating on behalf of all authors that the work has not been published and is not being considered for publication elsewhere.

Reformat to Hematological Oncology using Livewrite Premium

What are the publication costs?

$4,880 USD / £3,270 GBP / €4,110 EUR APC applies if the open access option is selected and the article is accepted and published.

Reformat to Hematological Oncology using Livewrite Premium

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CAR-T cell therapy research CNS Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders Acute Myeloid Leukemia Research Acute Lymphoblastic Leukemia research Lung Cancer Treatments and Mutations Chronic Myeloid Leukemia Treatments Multiple Myeloma Research and Treatments T-cell and Retrovirus Studies Monoclonal and Polyclonal Antibodies Research Immune Cell Function and Interaction Cutaneous lymphoproliferative disorders research Cancer Genomics and Diagnostics Immunodeficiency and Autoimmune Disorders Myeloproliferative Neoplasms: Diagnosis and Treatment Hematopoietic Stem Cell Transplantation Cancer Immunotherapy and Biomarkers Protein Degradation and Inhibitors Cancer Treatment and Pharmacology Multiple and Secondary Primary Cancers Diverse Scientific and Economic Studies Human auditory perception and evaluation Educational Robotics and Engineering

Related Journals

JO
Journal of Mammary Gland Biology and Neoplasia Springer Science+Business Media
BD
Bipolar Disorders WILEY
A&
Alzheimers & Dementia WILEY
WM
WIREs Mechanisms of Disease WILEY
JO
Journal of the National Cancer Center Elsevier BV
OA
OncoTargets and Therapy Dove Medical Press